Theravance Biopharma Inc (TBPH)
Working Capital Ratio
82.15%
Quarterly · Period ending:
TBPH Working Capital Ratio
Latest reported82.15%period ending
Latest reported82.15%period ending
TBPH Quarterly Working Capital Ratio (-56.47% → 82.15%)
Quarterly working capital ratio
High-resolution chart · PNG
TBPH working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 82.1457% | |
| 81.6956% | |
| 78.2911% | |
| 76.3708% | |
| 73.1538% | |
| 34.5658% | |
| 36.419% | |
| 26.1285% | |
| 26.6169% | |
| 27.6407% | |
| 28.4749% | |
| 32.9607% | |
| 37.4935% | |
| 43.6643% | |
| 53.4654% | |
| 48.4071% | |
| 33.8465% | |
| 45.1473% | |
| 51.0334% | |
| 57.3269% | |
| 61.9808% | |
| 55.0719% | |
| 57.5133% | |
| 67.642% | |
| 69.4296% | |
| 72.0468% | |
| 55.4723% | |
| 55.4252% | |
| 64.1494% | |
| 66.5752% | |
| 77.5155% | |
| 62.1562% | |
| 69.5866% | |
| 71.1588% | |
| 71.635% | |
| 65.4821% | |
| 60.2661% | |
| 63.3495% | |
| 74.9679% | |
| 64.1684% | |
| 69.019% | |
| 65.6208% | |
| 62.6431% | |
| 81.8657% | |
| 81.4391% | |
| 75.9321% | |
| 84.5286% | |
| 88.1626% | |
| 88.4495% | |
| -87.683% | |
| -90.3483% | |
| -78.4655% | |
| -73.3794% | |
| -39.1288% | |
| -56.4688% |